Tysabri every eight weeks may cut PML risk
Tysabri every eight weeks may cut PML risk
Preliminary findings from an ongoing study of multiple sclerosis patients suggest the dosing interval for Tysabri can be as much as doubled from the label-recommended standard without sacrificing efficacy, and with potentially less risk of progressive multifocal leukoencephalopathy (PML) -- even among patients with more than average PML risk, researchers claim... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2297 Views
-
Last post by NHE
-
- 6 Replies
- 6413 Views
-
Last post by ElliotB
-
- 0 Replies
- 1331 Views
-
Last post by NHE
-
- 0 Replies
- 3415 Views
-
Last post by NHE
-
- 1 Replies
- 1017 Views
-
Last post by NHE
-
- 1 Replies
- 1512 Views
-
Last post by NHE
-
- 11 Replies
- 3338 Views
-
Last post by NHE
-
- 0 Replies
- 3157 Views
-
Last post by NHE
-
- 0 Replies
- 1361 Views
-
Last post by NHE